Skip to content
February 26, 2025

Boosting Melanoma Immunity with Sequential IL-2 an...

Jack Kollings’ Abstract Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapyâ...

2 Minute Read
February 26, 2025

Defining drivers and metastatic risk of AP-1 heter...

Kimberly Nguyen’s Abstract Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, bring...

2 Minute Read
February 26, 2025

Mitigating Local Recurrence Risk for Melanoma Pati...

Anjali Devireddy’s Abstract Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The prese...

1 Minute Read
December 23, 2024

Tumor Draining Lymph Nodes to Predict Response to ...

August Culbert’s Abstract Metastatic melanoma remains a significant cause of death in the United States, with average survival rates below 35% just 5 years after init...

2 Minute Read
December 23, 2024

Outcomes and immune profile of type II diabetic pa...

Sabrina Bruno’s Abstract When melanoma is not found early, it can get into your blood and lymphatic systems and spread to other parts of your body. When this happens,...

2 Minute Read
December 23, 2024

Pre- and Post-Diagnosis Care Trends in New Maligna...

Kristen Curtis’ Abstract Objectives: Our main goal is to understand how demographic factors influence the medical care patterns of individuals diagnosed with malignan...

2 Minute Read
December 23, 2024

Effects of oxidative phosphorylation inhibition on...

Mayra Betancourt Ponce’s Abstract Metastatic melanoma is the most aggressive and deadliest type of skin cancer. Over the past decades, new therapies targeting mutatio...

2 Minute Read
December 23, 2024

Telomere Length-Promoting Mutational Landscape in ...

Alexandra Dubinsky’s Abstract Pediatric melanoma, a rare but aggressive form of skin cancer in children and young adults, poses a unique challenge for diagnosis and t...

1 Minute Read
December 23, 2024

Risk Analysis of US Disparities in Conjunctival Me...

Eric Kim’s Abstract Melanomas of the conjunctiva (CM) are very deadly. Knowledge regarding the social factors, especially insurance status such as Medicaid enrollment...

1 Minute Read
December 23, 2024

Role of Erythropoietin Receptor and RasGRP3 in Met...

Jayesh Menon’s Abstract Melanoma is the fifth most common cancer in the United States, with over 97,000 new cases diagnosed in 2023. Localized melanoma has favorable ...

2 Minute Read
December 23, 2024

A Bilingual Patient Education Community Program fo...

Hannah Riva’s Abstract Despite being the second most common group in the U.S. to be diagnosed with melanoma after non-Hispanic whites, Hispanics have significantly mo...

1 Minute Read
December 23, 2024

Addressing Disparities in Melanoma Outcomes

Nathan Shen’s Abstract Background Explained: Utah has the highest incidence of melanoma per 100,000 individuals in the United States. While fewer people from minority...

2 Minute Read

Dec 02, 2025 ET

Ask The Expert: LAG-3 Inhibitors: Exploring a New Path in Melanoma Treatment

Dec 06, 2025 ET

Tampa Bay Miles for Melanoma 5K

Dec 13, 2025 ET

Fort Myers Miles for Melanoma 5K

Feb 08, 2026 ET

Miami Miles for Melanoma 5K

Feb 22, 2026 ET

Orange County Miles for Melanoma 5K

Mar 01, 2026 ET - Mar 03, 2026

2026 Advocacy Days

Apr 17, 2026 ET - Apr 19, 2026

2026 Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium

Explore Events